# intestinal infections

Intestinal Infections Table



| Disease name | Causative organisms | Agent/vector | Agent factors | Source of infection | Infectivity | Secondary attack rate | Vector control measures | Age of host | Type of immunity | Special Effects during pregnancy if any | Environmental factors | Transmission | Incubation period | Clinical features | Complications | Diagnosis(all methods) | Prevention |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Poliomyelitis | Poliovirus types 1, 2, 3 (RNA virus) | Not in source | Type 1 is most paralytogenic; inactivated by heat (56°C), formaldehyde, chlorine, 2% iodine, and UV light; resistant to alcohol/phenol. | Infected humans (feces and oropharyngeal secretions of paralytic, mild, missed, and inapparent cases). | Highly communicable; most infectious 7-10 days before and after onset of symptoms. 90-95% of infections are inapparent. | Nearly 100% among susceptible household contacts. | Not applicable | Predominantly children under 5 years (95% of cases); highest vulnerability between 6 months and 3 years. | Type-specific long-lasting immunity from natural infection; vaccine-induced immunity (Humoral and Intestinal via OPV; Humoral only via IPV). | Pregnancy predisposes to the development of paralytic polio. | Warm temperature (20-30°C), 60% humidity, rainy season (June-Sept); poor sanitation and overcrowding favor spread. | Fecal-oral route (major); occasionally pharyngeal (droplet) route in acute phase; contaminated fingers, water, food, and flies. | 7 to 14 days for paralytic cases (range 3-35 days). | Inapparent (91-96%); Abortive (fever, sore throat); Non-paralytic (neck/back stiffness); Paralytic (asymmetrical flaccid paralysis, tripod sign, descending type). | Respiratory insufficiency, bulbar paralysis, residual flaccid paralysis/atrophy after 60 days, skeletal deformities. | Stool culture for virus isolation (highest yield within 2 weeks); CSF (excess leukocytes/protein); Clinical signs (AFP surveillance). | OPV (Sabin) and IPV (Salk) immunization according to schedule; Pulse Polio mass campaigns; improved sanitation and hand hygiene. |
| Hepatitis A | Hepatitis A virus (HAV), Enterovirus 72 (RNA virus) | Not in source | 27 nm virus; resistant to heat (withstands 56°C for 30 mins), acid, low pH, and ordinary chlorination; inactivated by boiling (5 mins) or UV rays. | Feces of infected persons (clinical, mild, or inapparent cases). | Maximum during the latter half of incubation period up to 1 week after jaundice onset. | Observed in about 20% of families. | Anti-fly measures. | Common in young adults; frequent but mild/subclinical in infants and children. | Permanent immunity after attack; IgM indicates acute infection, IgG indicates long-term. | Not in source | Overcrowding, poverty, unsafe water, poor sanitation; associated with heavy rainfall. | Mainly fecal-oral route; contaminated water/food/milk; rarely parenteral; sexual (homosexual men). | 15 to 50 days (Average 28-30 days). | Pre-icteric (fever, anorexia, nausea, headache); Icteric (jaundice, dark urine, tender palpable liver); Convalescent (malaise). | Fulminant hepatitis (rare), relapse (3-20% of cases). | Specific IgM antibodies (ELISA/RIA); detection of HAV in feces; 4-fold rise in paired sera; Serum transaminases (raised SGPT/SGOT). | Safe water supply (chlorination at breakpoint); sanitary disposal of excreta; Vaccines (Havrix, Vaqta); Human immunoglobulin for contacts. |
| Hepatitis E | Hepatitis E virus (HEV) (RNA virus) | Not in source | 29-32 nm particle; 4 genotypes (Type 1 common in India); no chronic form. | Feces of infected persons; infected animals. | Not in source | Not in source | Not applicable | Commonly adults (15-40 years); frequent but often asymptomatic in children. | Not in source | High case fatality rate (up to 20%) during the third trimester due to fulminant hepatic failure or obstetrical complications. | Water-borne outbreaks during monsoon; fecal contamination of water systems; limited resource settings. | Fecal-oral route (mainly contaminated water); food-borne (infected animal products); vertical (mother to fetus). | 15 to 64 days (Average 35-42 days). | Fever, malaise, anorexia, nausea, jaundice, hepatomegaly. | Fulminant hepatitis (especially in pregnancy); chronic infection in immunosuppressed. | Detection of specific IgM anti-HEV; detection of HEV RNA (RT-PCR) in blood or stool; serological exclusion of HAV/HBV. | Safe drinking water; sanitary excreta disposal; boiling water; vaccine (available in China). |
| Hepatitis B | Hepatitis B virus (HBV) (DNA Hepadnavirus) | Not in source | 42 nm double-shelled "Dane particle"; contains HBsAg, HBcAg, and HBeAg antigens; stable on environmental surfaces. | Infected humans (cases and chronic carriers); presence in blood, saliva, vaginal fluid, and semen. | HBeAg indicates high infectivity; virus present months to years in chronic carriers. | Not in source | Not applicable | All ages; widespread in children in developing countries; high risk of chronicity if infected perinatally. | Solid long-term immunity; Anti-HBs indicates immunity from infection or vaccine. | Vertical transmission (mother to infant) in last trimester or at birth; high risk of child becoming a chronic carrier. | Unsafe injection practices, inadequate blood screening, hospital waste management (needlesticks). | Parenteral (blood/needles), Vertical (perinatal), Permucosal (sexual contact, saliva). | 45 to 180 days (Average 60-90 days). | Insidious onset; anorexia, abdominal discomfort, nausea, jaundice, dark urine, arthralgia. | Chronic active hepatitis, cirrhosis, hepatocellular carcinoma (liver cancer), fulminant hepatitis. | Serology (HBsAg, anti-HBc IgM, HBeAg, anti-HBs); RIA/ELISA; HBV DNA by PCR. | HBV Vaccine (recombinant) at 0, 6, 10, 14 weeks; Hepatitis B Immunoglobulin (HBIG) for post-exposure; screening blood donors. |
| Hepatitis C | Hepatitis C virus (HCV) (RNA Flavivirus) | Not in source | 30-50 nm lipid-enveloped virus; high frequency of chronic infection. | Infected human blood and cases/chronic carriers. | Infective weeks before symptoms; persists indefinitely in carriers. | Not in source | Not applicable | All ages; commonly adults (15-29 years in drug users). | Degree of immunity unknown; repeated bouts reported. | Can be born to an HCV-infected mother; risk of transmission to fetus. | Infected blood products, paid blood donors, needle sharing. | Mainly parenteral (blood/needles/transfusion); perinatal; sexual (less common). | 2 weeks to 6 months (Average 6-9 weeks). | Often asymptomatic; insidious onset, anorexia, fatigue, mild jaundice. | Chronic liver disease (55-85%), cirrhosis (15-30%), hepatocellular carcinoma. | Serologic test for anti-HCV (ELISA); HCV RNA (PCR); confirmation via RIBA or NAT. | Screening of blood products; avoidance of shared needles; health education; no current vaccine. |
| Hepatitis D | Hepatitis delta virus (HDV) (Defective RNA virus) | Not in source | 35-37 nm particle; requires HBsAg (HBV coinfection) for replication. | Blood and body fluids of HBV-infected individuals/carriers. | Not in source | Not in source | Not applicable | Same as Hepatitis B (populations at high risk of HBV). | Prevented by HBV vaccine. | Vertical transmission possible but rare. | Similar to HBV; high prevalence in Mediterranean and Middle East. | Parenteral; sexual; coinfection or superinfection with HBV. | 2 to 10 weeks (Range 2-12 weeks). | Abrupt onset; severe hepatitis symptoms in HBV carriers. | Rapid progression to cirrhosis, fulminant hepatitis. | Detection of Delta-antigen or anti-HDV (IgG and IgM) in HBsAg positive patients; HDV RNA in serum. | Hepatitis B immunization (prevents HDV infection); blood and injection safety. |
| Acute Diarrhoeal Diseases | Various: Bacterial (V. cholerae, E. coli, Shigella, Salmonella, Campylobacter), Viral (Rotavirus, Norwalk), Protozoal (Giardia, Cryptosporidium) | Houseflies (mechanical vector) | Multiple antigenic types; many survive in water/food; Rotavirus responsible for 25-50% of childhood cases. | Human or animal feces/vomitus (cases or carriers); contaminated environment. | Communicable during acute diarrhoeal stage; highly infectious through fecal contamination. | High in families; increases with family size. | Fly control (eliminating breeding sites, garbage storage). | Infants and children under 5 years are most vulnerable (high risk during weaning). | Natural immunity develops with age/repeated exposure; short-lived usually. | Risk of dehydration and preterm labour. | Unsafe water, poor sanitation, overcrowding, seasonal peaks (bacterial in summer, viral in winter). | Fecal-oral route; contaminated food/water; fingers/fomites; mechanical transmission by flies. | Few hours to 5 days (Rotavirus 1-3 days). | Frequent loose stools, vomiting, fever, abdominal pain, signs of dehydration (sunken eyes, dry tongue). | Severe dehydration, electrolyte imbalance, metabolic acidosis, malnutrition, death. | Clinical assessment of dehydration; stool microscopy and culture; RDT for Rotavirus. | ORS and Zinc; exclusive breastfeeding; hand washing; sanitation; Rotavirus and measles vaccines. |
| Cholera | Vibrio cholerae (O1 Classical/El Tor and O139) | Flies act as potential mechanical vectors | Gram-negative, motile; produces enterotoxin (exotoxin); survives well in water/ice; killed by heat (56°C) and chlorine. | Stools and vomit of infected human beings (cases and carriers). | Case infectious for 7-10 days; convalescent carriers 2-3 weeks; chronic carriers for years. | Not in source | Food protection and environmental sanitation to reduce fly population. | All ages; in endemic areas, attack rate highest in children. | Antibacterial and antitoxic immunity; vaccination gives temporary partial immunity (3-6 months). | High risk of miscarriage due to hypovolemic shock. | Contaminated water/wells, sewage pollution, fairs and festivals, disasters (floods). | Fecal-oral route via contaminated water/food; direct person-to-person contact. | A few hours to 5 days (Average 1-2 days). | Sudden onset of painless watery "rice-water" stools, projectile vomiting, rapid dehydration, muscular cramps, "washerman's hands." | Hypovolemic shock, renal failure, acidosis, death (30-40% fatality if untreated). | Stool culture (Bile Salt Agar/TCBS); Dark-field microscopy ("shooting stars" motility); RDT. | Safe water (chlorination); sanitary latrines; food hygiene; Oral Cholera Vaccines (Dukoral, Sanchol). |
| Typhoid fever | Salmonella typhi; S. paratyphi A, B, C | Flies act as mechanical vectors | Gram-negative rod with O, H, and Vi antigens; survives in water, ice, and food; sensitive to heat (>70°C). | Feces and urine of human cases or carriers (chronic carriers are primary sources). | As long as bacilli appear in excreta (can be years in carriers). | 10% transmission rate noted in comparisons. | Fly control and protection of food. | Highest incidence in 5-19 years age group; peak in males. | Humoral and cell-mediated immunity; natural attack doesn't always confer solid immunity. | Risk of abortion and premature birth. | Poor sanitation, open drainage, rainy season (July-Sept), sewage contamination of water/milk. | Fecal-oral or urine-oral route via contaminated water, food, fingers, or flies. | Usually 10-14 days (range 3-21 days). | Continuous "step-ladder" fever, headache, malaise, abdominal pain, rose spots (2nd week), splenomegaly, "pea soup" diarrhea. | Intestinal perforation (3rd week), intestinal hemorrhage, myocarditis, cholecystitis. | Blood culture (1st week); Widal test (after 1st week); stool/urine culture; Typhidot/Dipstick. | Typhoid vaccines (Oral Ty21a, Injectable Vi, TCV); safe water; food hygiene; carrier detection/treatment. |
| Food poisoning | Salmonella, Staphylococcus aureus, Cl. botulinum, Cl. perfringens, B. cereus | Flies, rodents, or fomites | Preformed toxins in food; toxins can be heat stable (Staph) or heat labile (Botulism). | Contaminated meat, milk, poultry, eggs; infected food handlers; rodents; soil (Botulism). | Not applicable (no secondary waves). | None (Point source). | Fly and rodent control in food premises. | All ages; more serious in elderly (>65) and young children (<5). |  | Dehydration risk. | Warm temperatures (10-49°C danger zone); poor food storage; community feeding. | Ingestion of contaminated food or drink (5 Fs: flies, fingers, food, fluid, fomites). | 1-6 hours (Staph), 12-24 hours (Salmonella), 12-36 hours (Botulism). | Sudden onset nausea, vomiting, abdominal cramps, diarrhea; Botulism: diplopia, dysphagia, muscle weakness. | Dehydration, respiratory failure (Botulism), shock, epidemic dropsy (if oil adulterated). | Clinical history; culture of stool/vomit/remnants of food; animal feeding experiments (mice). | Food sanitation (meat inspection); personal hygiene; refrigeration (<4°C); thorough cooking. |
| Amoebiasis | Entamoeba histolytica (Protozoa) | Flies, cockroaches, and rodents act as vectors | Cysts are the infective form; resistant to chlorine (1 ppm) and low temperatures; destroyed by heat (>55°C). | Human feces (chronic patients and asymptomatic cyst passers). | Period as long as cysts are excreted (may be several years). | High in families. | Control of flies and cockroaches in food areas. | All ages affected; symptomatic disease less common under 10 years in some zones; common in adolescents. | Specific antibodies produced upon tissue invasion; immunity to reinfection not clearly demonstrated. | Not in source | Poor sanitation, use of nightsoil as fertilizer, leaking water pipes, overcrowding. | Fecal-oral route; contaminated water/food; direct hand-to-mouth; sexual (oro-anal). | 2 to 4 weeks (range days to years). | Mild abdominal discomfort to acute dysentery (blood/mucus stools), tenesmus, liver abscess symptoms. | Liver abscess (extra-intestinal), lung/brain involvement (rare), intestinal perforation/ulceration. | Stool microscopy (trophozoites or cysts); Serology (IHA, ELISA); Liver imaging (USG). | Sanitary disposal of excreta; safe water supply (sand filtration); personal hygiene (hand washing). |
| Ascariasis | Ascaris lumbricoides (Helminth/Roundworm) | Not in source | Eggs are very hardy and survive in soil for years; female passes ~200,000 eggs/day. | Human feces containing eggs (infected man). | As long as mature female worms live in intestine; embryonated eggs are infective. | Not in source | Not applicable | Primarily preschool and school children (3-15 years); incidence falls after age 15. | Partial; adults acquire some resistance. | Malnutrition risk. | Polluted/clay soil; humid/moist conditions; lack of proper nightsoil disposal. | Ingestion of infective (embryonated) eggs from contaminated food, water, soil, or fingers. | 2 to 3 months for development into adult worms. | Vague abdominal pain, cough, Loffler's syndrome (pulmonary phase), irritability, passing worms. | Intestinal obstruction, biliary disease, malnutrition, growth retardation in children. | Stool microscopy for characteristic fimbriated eggs; identification of adult worms. | Periodic deworming (Albendazole/Mebendazole); sanitary latrines; hand washing; washing vegetables. |
| Hookworm | Ancylostoma duodenale, Necator americanus (Helminth) | Not in source | Larvae hatch in soil and become infective (filariform) in 5-10 days; survive up to 2 years in damp soil. | Soil contaminated with infective larvae (derived from human feces). | As long as person harbours parasite (worms live 1-4 years). | Not in source | Not applicable | All ages, especially adults working barefoot in agricultural fields (15-25 years). | Resistance develops only after years of exposure. | Severe anaemia leading to low birth weight, maternal death, and impaired lactation. | Damp sandy/porous soil; warm temperatures (24-32°C); rainfall >100cm; open-air defecation. | Larval penetration of skin (usually feet); rarely ingestion of larvae (A. duodenale). | Weeks to months (5 weeks to 9 months). | Ground itch (at entry site), iron deficiency anaemia (pallor, fatigue, breathlessness), epigastric discomfort. | Severe chronic anaemia, hypoalbuminaemia, retarded physical/cognitive development, cardiac failure. | Stool microscopy (eggs); Chandler's Index (egg count); Kato-katz technique. | Use of footwear; sanitary latrines; periodic mass deworming (Albendazole 400mg). |
| Dracunculiasis | Dracunculus medinensis (Guinea worm) | Cyclops (water flea/intermediate host) | Larvae must be swallowed by cyclops to develop (15 days); female worm 55-120 cm. | Infected human (discharging larvae from skin blister into water). | Until the worm is extracted or larvae are no longer discharged. | Not in source | Chemical (Abate/Temephos 1 ppm); biological (Barbel fish); converting stepwells. | All ages affected. | None; multiple and repeated infections are common. | Worm may appear on breast skin. | Linked to stagnant water sources (stepwells, tanks, ponds); restricted to tropics. | Ingestion of drinking water containing infected cyclops. | About one year (Biological incubation). | Blister (usually on leg/foot) that bursts when wet; burning pain, inflammation, emerging worm. | Secondary bacterial infection of the ulcer, joint stiffness/arthritis, permanent disability. | Clinical observation of the worm/blister; microscopic detection of larvae in fluid; Ramsay's test. | Boiling/filtering water (6 mesh cloth); providing hand pumps; preventing patients from entering water. |